Valeant Pharmaceuticals International, Inc. (VRX: Quote,VRX.TO: Quote) Friday said it has completed acquisition of Natur Produkt International, JSC, for approximately $163 million, plus adjustments for net debt and working capital.
Natur Produkt is a specialty pharmaceutical company in Russia, and has a significant presence in the OTC segment in several categories marketed under the umbrella brand, Natur Produkt.
Click here to receive FREE breaking news email alerts for Valeant Pharmaceuticals International and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org